Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints
D. Magouliotis (Larissa, Greece), V. Tasiopoulou (Larissa, Greece), K. Spiliopoulos (Larissa, Greece), K. Svokos (Providence, RI, United States of America), A. Svokos (Lewisburg, PA, United States of America), K. Athanassiadi (Athens, Greece)
Source: International Congress 2019 – All aspects of general thoracic surgery
Session: All aspects of general thoracic surgery
Session type: Oral Presentation
Number: 3787
Disease area: Respiratory infections, Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Magouliotis (Larissa, Greece), V. Tasiopoulou (Larissa, Greece), K. Spiliopoulos (Larissa, Greece), K. Svokos (Providence, RI, United States of America), A. Svokos (Lewisburg, PA, United States of America), K. Athanassiadi (Athens, Greece). Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints. 3787
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience Source: International Congress 2017 – General thoracic surgery Year: 2017
Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003
Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Role of surgery and of radiotherapy in malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Possibilities of reconstruction during pleuropneumonectomy with resection of pericardium and diaphragm in patients with malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma Source: Eur Respir J , 49 (3) 1601428; DOI: 10.1183/13993003.01428-2016 Year: 2017
Malignant pleural mesothelioma: our multimodality approach Source: Eur Respir J 2002; 20: Suppl. 38, 40s Year: 2002
Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005
Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource Source: Eur Respir J 2007; 30: 1021 Year: 2007